## Abstract Several studies had been carried out on anti‐hepatitis C virus (HCV) prevalence in populations with blood exposure risks and in blood donors. New tests are now available which allow the in‐ vestigation to extend to other parameters such as antibody type and HCV‐RNA. In this study the p
Low prevalence of antibody to hepatitis C virus in North East England
✍ Scribed by A. M. Brind; A. A. Codd; B. J. Cohen; F. G. Gabriel; J. D. Collins; O. F. W. James; Dr. M. F. Bassendine
- Publisher
- John Wiley and Sons
- Year
- 1990
- Tongue
- English
- Weight
- 635 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The prevalence of antibodies to hepatitis C virus (anti‐HCV) was studied in North East England in blood donors, local multiply transfused patients, local high risk individuals, and chronic liver disease patients. Anti‐HCV was detected by enzyme‐linked immunosorbent assay (ELISA) in 2/1120 (0.18%) blood donors; 1/84 chronic renal failure patients on haemodialysis who had received 1,992 units of blood (seroconversion rate of 0.05% per unit transfused), 1/207 cardiac patients 6 months post cardiac surgery transfused with 1,403 units of blood (1 anti‐HCV pre‐operatively, seroconversion rate 0.07%), 40/50 haemophilia A patients treated with commercial factor VIII, and 38/100 intravenous drug users. In addition anti‐HCV was detected by ELISA in 5/35 cryptogenic chronic liver disease patients, 5/5 confirmed by recombinant immunoblot assay (RIBA) (14%); 3/30 patients with autoimmune chronic active hepatitis, 2/3 by RIBA (7%); 2/50 primary biliary cirrhosis patients, 1/2 by RIBA (2%); 0/30 alcoholic cirrhosis patients; and 2/9 patients with hepatocellular carcinoma, 1/2 by RIBA (11%). HCV is uncommon in North East England; it may be implicated in the aetiology of a minority of cases of cryptogenic liver disease and <5% of autoimmune chronic active hepatitis and primary biliary cirrhosis.
📜 SIMILAR VOLUMES
## Abstract To evaluate the prevalence of hepatitis C virus infection in northwest China, 179 chronic liver disease patients in this area were examined for antibody to hepatitis C virus core protein (anti‐HCVcore). This antibody was found in only 5 (14 percent) of 37 chronic non‐A, non‐B liver dise
Many cases of chronic hepatitis and cirrhosis cannot be attributed to a known cause and are collectively referred to as cryptogenic chronic liver disease. We have evaluated the role of the hepatitis C virus in the pathogenesis of this condition in a retrospective serum analysis for antibody to hepat
## Abstract Seventy‐four patients who were maintained on chronic haemodialysis in King Khalid University Hospital, Riyadh, Saudi Arabia were tested using the recently available ELISA to determine the prevalence of antibodies to hepatitis C virus (anti‐HCV) in a haemodialysis unit. The prevalence r
## Abstract To evaluate whether hepatitis C virus (HCV) infection is an occupational hazard in the dental environment, serum samples collected in 1990–1991 from 461 dentists were tested for the antibody to HCV (anti‐HCV) with first‐ and second‐generation HCV enzyme‐linked immunoassays (EIAs). Five